Clinical

Dataset Information

0

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BMS-247550 in treating patients who have recurrent or metastatic colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2006586 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Json Xml

Similar Datasets

Clinical BMS-247550 in Treating Patients With Advanced Cancers
| 2005268 | ecrin-mdr-crc
Clinical BMS-247550 in Treating Patients With Metastatic Colorectal Cancer
| 2007345 | ecrin-mdr-crc
Clinical Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
| 2006232 | ecrin-mdr-crc
Clinical Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2003275 | ecrin-mdr-crc
Clinical Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
| 2004952 | ecrin-mdr-crc
Clinical Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2002537 | ecrin-mdr-crc
Clinical SarCNU in Treating Patients With Recurrent or Metastatic Colorectal Cancer
| 2006976 | ecrin-mdr-crc
Clinical Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
| 2006502 | ecrin-mdr-crc
Clinical Rebeccamycin Analog in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
| 2004187 | ecrin-mdr-crc
Clinical NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
| 2007222 | ecrin-mdr-crc